Traditional Dosage Forms
Robust development of oral tablets, capsules, and injectables.
01
Small Molecules
Advancing Small Molecule Therapies with Confidence
Small molecules remain the backbone of modern therapeutics, representing the majority of FDA-approved drugs and active development pipelines. While biologics play an equally important role, CMC Pharma focuses on what we know best—the development of small molecule drug products. Many of our clients come to us with a strong background and focus on discovery and biology, while we bring the chemistry and manufacturing expertise needed to advance their programs. We also believe true success requires more than strong science: it demands efficient development, regulatory alignment, and manufacturability built in from the very beginning.
- At CMC Pharma, we specialize in small molecule drug development services from discovery through commercialization, providing a unique combination of:
- Formulation & Analytical Development in our full-service laboratories
- Stability & Compatibility Testing aligned with ICH guidelines
- Prototype Preparation & Manufacturing Enablement for rapid scale-up
- Integrated Regulatory Support to anticipate and meet FDA/ICH requirements
We offer a flexible, faster, and more cost-effective model than other CDMOs. We de-risk your entire development pathway through manufacturing, ensuring that every study and data point supports your long-term success.
Therapeutic Area Experience
- Our small molecule expertise spans a wide range of therapeutic areas, including:
- Oncology: Cytotoxic and targeted small molecules, including HPAPIs.
- Cardiovascular & Circulatory Medicine: Stable, scalable formulations for large patient populations.
- Neuroscience & Mental Health: CNS-active drugs requiring complex delivery or bioavailability solutions.
- Endocrinology & Metabolic Diseases: Chronic-use therapies with long-term stability requirements.
- Orthopedic & Anti-Inflammatory: Controlled substances and anti-inflammatory compounds for pain management.
- Infectious Diseases & Immunology: Antivirals, antibiotics, and critical medical countermeasures.
- Animal Health: Veterinary dosage forms and delivery systems tailored to species-specific needs.
By bringing expertise across these therapeutic areas and more, CMC delivers both depth of knowledge and transferable insight that strengthens development programs.
Integrated Development to Submission-Ready Data
Unlike many large CDMOs, we prioritize your early stage development program. CMC Pharma provides the capacity, speed, and focus to move your project forward without unnecessary stalls and delays. We execute quickly and efficiently, ensuring your timelines stay intact.
One of the most common reasons small molecule programs stall is a disconnect between laboratory execution and regulatory requirements. At CMC Pharma, regulatory expertise is fully integrated into our development process, so every experiment, every batch, and every stability study generates submission-ready data. This eliminates costly rework, prevents delays, and keeps your program aligned with FDA and ICH expectations from the very beginning. Plus, the integration prevents the need for you to hire additional consultants or vendors, which often results in miscommunication and unnecessary hand-offs.
- Our services include:
- Formulation & process optimization designed with scalability in mind
- Analytical method development & validation built for compliance
- ICH stability studies producing FDA/EMA-ready reports
- Manufacturing enablement (scale-up, tech transfer, and CMO oversight)
- Collaborative IND/NDA preparation, and review.
Our unique model accelerates development, reduces risk, and ensures your small molecule program is positioned for approval without the inefficiencies common at larger CDMOs.
Why Choose CMC Pharma Over Other CDMOs?
Most CDMOs focus on manufacturing capacity. Many consultants provide meaningful direction and study design but lack labs to execute. Testing labs often deliver isolated data without context.
- CMC Pharma is different. We are a non-traditional CDMO and full-service development partner that integrates:
- A development laboratory capable of formulation, analytical, and stability studies
- Manufacturing enablement through prototype production (RAMP), scale-up, and CMO identification, qualification, and management
- Regulatory expertise that ensures your data is not just scientifically sound, but submission-ready
This model means
- Fewer hand-offs → lower risk of misalignment
- Faster timelines → fewer delays in clinical entry and commercialization
- Lower overall cost → reduced need for multiple vendors or additional hires
We are more than a vendor: our clients gain a strategic partner committed to advancing their small molecule program successfully.
Partner with CMC Pharma
From oncology therapies to medical countermeasures, from traditional dosage forms to novel delivery systems, CMC Pharma provides the expertise, oversight, and regulatory integration that small molecule programs need to succeed.
Partner with us to de-risk development, accelerate timelines, and bring your therapies to patients faster.
Send a message
Contact Us Today and find out how CMC Pharma can help you!
Whether you need to develop robust analytical methods or require routine testing. Contact CMC Pharma to learn how we can help you advance your development program.
Send us a message or give us a call at 440-485-1734.